Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVIPLEX plasma exchange in severe COVID-19
2020-002668-29Phase 2Unknown
- Sponsor
- University College London
- Start
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in coronavirus disease 2019 (COVID-19) comparing Plasma exchange (OctaplasLG) + standard of care with Standard of care alone (2 arms). Primary endpoint: Primary reduction in inflammatory markers. Status: unknown.
02
Drugs
octaplas lg
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-002668-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002668-29.